Insmed Inc. buy The Goldman Sachs Group, Inc.
Start price
15.05.24
/
50%
€23.00
Target price
15.05.25
€45.11
Performance (%)
123.91%
Price
03.06.24
€50.50
Summary
This prediction is currently active. The BUY prediction by The_Goldman_Sachs_Gr for Insmed Inc. has seen massive gains of 123.91%. This prediction currently runs until 15.05.25. The prediction end date can be changed by The_Goldman_Sachs_Gr at any time. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Insmed Inc. | 150.000% |
| iShares Core DAX® | -1.226% |
| iShares Nasdaq 100 | -1.845% |
| iShares Nikkei 225® | -1.132% |
| iShares S&P 500 | -0.980% |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread Insmed Inc. diskutieren
Insmed Incorporated (NASDAQ: INSM) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $40.00 to $49.00. They now have a "buy" rating on the stock.
Ratings data for INSM provided by MarketBeat